Endosialin	O
/	O
TEM	O
1	O
/	O
CD248	O
is	O
a	O
pericyte	B-Cell
marker	O
of	O
embryonic	B-Developing_anatomical_structure
and	O
tumor	B-Cancer
neovascularization	O
.	O

The	O
formation	O
of	O
functional	O
,	O
mature	O
blood	B-Multi-tissue_structure
vessels	I-Multi-tissue_structure
depends	O
on	O
the	O
interaction	O
between	O
endothelial	B-Cell
cells	I-Cell
and	O
pericytes	B-Cell
.	O

Commonality	O
exists	O
in	O
the	O
processes	O
involved	O
in	O
vasculature	B-Multi-tissue_structure
development	O
between	O
tissues	B-Tissue
whether	O
healthy	O
or	O
diseased	O
.	O

Endosialin	O
/	O
TEM	O
1	O
is	O
a	O
cell	B-Cellular_component
membrane	I-Cellular_component
protein	O
that	O
is	O
expressed	O
in	O
blood	B-Multi-tissue_structure
vessels	I-Multi-tissue_structure
during	O
embryogenesis	O
and	O
tumorigenesis	O
but	O
not	O
in	O
normal	O
mature	B-Multi-tissue_structure
vessels	I-Multi-tissue_structure
.	O

Antibodies	O
developed	O
to	O
human	O
endosialin	O
were	O
used	O
to	O
investigate	O
endosialin	O
expression	O
and	O
function	O
in	O
human	O
prenatal	B-Cell
brain	I-Cell
pericytes	I-Cell
and	O
pericytes	B-Cell
residing	O
in	O
tumors	B-Cancer
.	O

Anti	O
-	O
endosialin	O
was	O
capable	O
of	O
preventing	O
pericyte	B-Tissue
tube	I-Tissue
formation	O
in	O
culture	O
and	O
inhibited	O
migration	O
.	O

Brain	B-Cell
pericytes	I-Cell
in	O
culture	O
had	O
higher	O
levels	O
of	O
endosialin	O
/	O
TEM	O
1	O
than	O
TEMs	O
-	O
2	O
,	O
-	O
3	O
,	O
-	O
4	O
,	O
-	O
5	O
,	O
-	O
7	O
,	O
and	O
-	O
8	O
.	O

Immunocytochemistry	O
revealed	O
that	O
endosialin	O
was	O
present	O
in	O
the	O
cytoplasmic	B-Organism_substance
body	I-Organism_substance
and	O
in	O
the	O
elongated	O
extensions	O
essential	O
to	O
pericyte	B-Cell
function	O
.	O

Transgenic	O
mice	O
engineered	O
to	O
express	O
human	O
endosialin	O
bred	O
on	O
an	O
immunocompromised	O
background	O
allowed	O
the	O
growth	O
of	O
human	O
tumor	B-Cancer
xenografts	I-Cancer
.	O

In	O
human	O
colon	B-Cancer
carcinoma	I-Cancer
Colo205	I-Cancer
and	O
HT29	B-Cancer
xenografts	I-Cancer
grown	O
in	O
human	O
endosialin	O
-	O
transgenic	O
mice	O
,	O
endosialin	O
expression	O
was	O
largely	O
confined	O
to	O
NG2	O
-	O
expressing	O
perivascular	B-Cell
cells	I-Cell
and	O
not	O
CD31	B-Cell
-	I-Cell
positive	I-Cell
endothelial	I-Cell
cells	I-Cell
.	O

Similar	O
methods	O
applied	O
to	O
human	O
ovarian	B-Cancer
and	O
colon	B-Cancer
tumors	I-Cancer
confirmed	O
endosialin	O
expression	O
by	O
pericytes	B-Cell
.	O

The	O
data	O
indicate	O
that	O
endosialin	O
is	O
strongly	O
expressed	O
by	O
pericytes	B-Cell
during	O
periods	O
of	O
active	O
angiogenesis	O
during	O
embryonic	B-Developing_anatomical_structure
and	O
tumor	B-Cancer
development	O
.	O

Anti	O
-	O
endosialin	O
antibodies	O
may	O
have	O
value	O
in	O
identifying	O
vasculature	B-Multi-tissue_structure
in	O
malignant	B-Tissue
tissues	I-Tissue
.	O

With	O
the	O
appropriate	O
agent	O
,	O
targeting	O
endosialin	O
may	O
interfere	O
with	O
blood	B-Multi-tissue_structure
vessel	I-Multi-tissue_structure
growth	O
during	O
tumor	B-Cancer
development	O
.	O

